CAREDX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 108.50K shares, a 7.89% increase year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 28.71K shares, a 79.65% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 85.64K shares, a 72.84% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 29.14K shares, a 84.80% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 356.38K shares, a 32.38% decline from fiscal 2024.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 527.01K shares, a 1788.72% increase from fiscal 2023.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 27.90K shares, a 80.43% decline from fiscal 2022.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 142.58K shares, a 81.07% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 108.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | 251.98K shares derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | 28.71K shares 10-Q · filed 2026-04-28 | 244.04K shares derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | 85.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 356.38K shares 10-K · filed 2026-02-25 |
| 2025-09-30 | 29.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 586.06K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 100.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 748.58K shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 141.05K shares 10-Q · filed 2025-04-30 | 666.56K shares derived: sum of 4 quarters · filed 2025-04-30 |
| 2024-12-31 | 315.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 527.01K shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 191.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 216.40K shares derived: sum of 4 quarters · filed 2024-11-04 |
| 2024-06-30 | 18.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | 44.19K shares derived: sum of 4 quarters · filed 2024-07-31 |
| 2024-03-31 | 1.50K shares 10-Q · filed 2024-05-09 | 28.58K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 4.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 27.90K shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 19.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 67.26K shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 2.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 57.00K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 820.00 shares 10-Q · filed 2023-05-10 | 73.41K shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 44.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 142.58K shares 10-K · filed 2023-02-27 |
| 2022-09-30 | 9.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 205.18K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 19.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 276.07K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 69.99K shares 10-Q · filed 2022-05-05 | 683.80K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 106.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 753.38K shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 80.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | 929.14K shares derived: sum of 4 quarters · filed 2021-10-28 |
| 2021-06-30 | 427.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | 1.01M shares derived: sum of 4 quarters · filed 2021-07-29 |
| 2021-03-31 | 139.58K shares 10-Q · filed 2021-05-05 | 783.54K shares derived: sum of 4 quarters · filed 2021-05-05 |
| 2020-12-31 | 282.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | 688.82K shares 10-K · filed 2021-02-24 |
| 2020-09-30 | 159.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | 459.04K shares derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-06-30 | 201.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 380.93K shares derived: sum of 4 quarters · filed 2020-08-04 |
| 2020-03-31 | 44.86K shares 10-Q · filed 2020-04-30 | 418.81K shares derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-12-31 | 52.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | 625.68K shares 10-K · filed 2020-02-28 |
| 2019-09-30 | 81.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 764.23K shares derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | 239.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 796.85K shares derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-31 | 251.74K shares 10-Q · filed 2019-05-08 | 583.00K shares derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-12-31 | 191.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 472.64K shares 10-K · filed 2019-03-06 |
| 2018-09-30 | 114.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 353.44K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 25.99K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 239.35K shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 141.39K shares 10-Q · filed 2018-05-10 | 213.36K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 71.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | 71.98K shares 10-K · filed 2018-03-22 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-06-09 | |
| 2016-12-31 | 5.69K shares 10-K · filed 2018-03-22 | |
| 2016-03-31 | 1.82K shares 10-Q · filed 2016-05-16 | |
| 2015-12-31 | 23.58K shares 10-K · filed 2018-03-22 | |
| 2015-09-30 | 23.28K shares 10-Q · filed 2015-11-13 | 47.49K shares derived: sum of 4 quarters · filed 2017-04-21 |
| 2015-06-30 | 13.34K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 25.05K shares derived: sum of 4 quarters · filed 2017-04-21 |
| 2015-03-31 | 4.55K shares 10-Q · filed 2015-05-14 | |
| 2014-12-31 | 6.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-21 | 9.36K shares 10-K · filed 2017-04-21 |
| 2014-09-30 | 839.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | |
| 2013-12-31 | 212.00 shares 10-K · filed 2016-03-29 | |
| 2012-12-31 | 2.92K shares 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |